✓ Verificato
Punteggio di affidabilità 98/100
Dr. Hariharan Kuhan
· London
👤 6 anni di esperienza
6,915+
Patients seen
6
Years in practice
9
Publications
1
Languages spoken
Informazioni
Dr Hariharan Kuhan is the Co-Founder and Medical Director of Lucio Health, where he leads the development of personalised, data-driven approaches to cancer and metabolic health. His clinical background spans mainstream oncology, early-phase trials, and academic research, with a strong focus on integrating metabolic medicine into modern cancer care.
Dr Kuhan studied medicine at Imperial College London, graduating with a BSc in Surgery and Anaesthesia. He completed his foundation and core medical training at major central London teaching hospitals before specialising in medical oncology at recognised UK centres of excellence.
During his research fellowship at Barts Cancer Institute, he explored metabolic pathways in cancer stem cells and circulating tumour cells, contributing to translational research that progressed into phase I human trials. He later served as a clinical fellow within a Harley Street early-phase trials unit, where he acted as lead sub-investigator on multiple solid tumour studies.
Dr Kuhan continues to be actively involved in clinical research and drug development. His expertise encompasses oncology, metabolic targeting, repurposed therapeutics, and genomic profiling, giving him a distinctive ability to bridge cutting-edge science with practical, patient-centred care. He is particularly passionate about making innovative, evidence-based treatments more accessible and supporting patients through truly personalised medicine.
Dr Kuhan studied medicine at Imperial College London, graduating with a BSc in Surgery and Anaesthesia. He completed his foundation and core medical training at major central London teaching hospitals before specialising in medical oncology at recognised UK centres of excellence.
During his research fellowship at Barts Cancer Institute, he explored metabolic pathways in cancer stem cells and circulating tumour cells, contributing to translational research that progressed into phase I human trials. He later served as a clinical fellow within a Harley Street early-phase trials unit, where he acted as lead sub-investigator on multiple solid tumour studies.
Dr Kuhan continues to be actively involved in clinical research and drug development. His expertise encompasses oncology, metabolic targeting, repurposed therapeutics, and genomic profiling, giving him a distinctive ability to bridge cutting-edge science with practical, patient-centred care. He is particularly passionate about making innovative, evidence-based treatments more accessible and supporting patients through truly personalised medicine.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Hariharan Kuhan
Istruzione e formazione
-
2010–2016 MD · Medicine and Surgery
-
2016–2020 Residency
-
2020–2021 Fellowship · Subspecialty training
Carriera e incarichi
-
2020-09–2021-08 Junior consultant
Licenze e assicurazione
Licenze mediche
GB — Organización Médica Colegial de España (OMC)
Certificazioni di specializzazione
European Board of
Assicurazione responsabilità professionale:
Generali Healthcare · 4,000,000 EUR copertura · No claims on file
Procedure eseguite
| Procedura | Codice | Conteggio totale |
|---|---|---|
| GP consultation | 99213 | 1,527 |
| Annual physical exam | 99395 | 2,361 |
| Vaccination administration | 90471 | 417 |
| Minor procedure (skin) | 17110 | 2,758 |
Servizi e prezzi
| Servizio | Durata | Modalità | Prezzo |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 540.00 EUR |
Studio, team e in pratica
Video
Ricerca e pubblicazioni
indice h: 18 · i10: 9
-
Outcomes of in adults — a multi-centre cohort
DOI: 10.1289/euroclin.2025.0 · PMID: 33124820 · citato da 39
-
European registry analysis of outcomes
DOI: 10.6802/euroclin.2024.1 · PMID: 30650891 · citato da 157
Conferenze su invito
- Practical updates in European Annual Congress () · Vienna · 2024 · invited
- Single-centre experience in National Society Meeting · London · 2023 · oral abstract
Premi e affiliazioni
Premi
- 🏆 Top-rated — London · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Iscrizioni a società
- WONCA Europe — Family Doctors — Member · Dal 2021
- national college of family doctors — Member · Dal 2021
- European Union of Medical Specialists (UEMS) — Member · Dal 2021
Articoli di questo medico
- Patient education Patient guide to
- Awareness When should you see a ?
Per pazienti internazionali
- Coordinatore
- Patient liaison · hariharan.kuhan@euroclinics.example
- Assicurazioni internazionali accettate
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Posizione
1 tagRecensioni dei pazienti
26 recensioni verificate5.00
★★★★★
26 recensioni
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Condividi la tua esperienza — aiuta altri pazienti a trovare il medico giusto. Scrivi una recensione →
Recensioni recenti
-
★★★★★ ✓ Verificato Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificato Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificato Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.